SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) — FDA Approval ANDA205941 (AMNEAL)
SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) — FDA Approval ANDA205941 (AMNEAL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SAXAGLIPTIN; Active ingredients: SAXAGLIPTIN HYDROCHLORIDE; Application number: ANDA205941.
| Brand name | SAXAGLIPTIN |
|---|---|
| Active ingredients | SAXAGLIPTIN HYDROCHLORIDE |
| Application number | ANDA205941 |
| Sponsor | AMNEAL |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20230731 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →